Mondelez International, Inc. (MDLZ) › Analysis

Mondelez International, Inc. (MDLZ) analysis, March 10, 2026

Published March 10, 2026 · MDLZ chart, levels and live analysis

Key Updates

Mondelez shares declined 2.40% to $56.58 since the March 5 report, extending the downtrend to seven consecutive sessions and breaking below the $57 psychological support level. The selloff intensified following CEO Dirk Van de Put's defensive comments on processed foods amid regulatory scrutiny, which triggered a 4.4% single-day decline on February 18. Despite the near-term pressure, Morningstar reaffirmed its wide-moat rating and projects 10% earnings growth through 2029, while the stock maintains a 5.11% YTD gain and trades at an 18% discount to fair value with a 3.3% dividend yield.

Current Trend

MDLZ demonstrates divergent performance across timeframes, posting a 5.11% YTD gain while experiencing sustained selling pressure across all shorter intervals: down 2.73% over one day, 3.73% over five days, 5.73% over one month, and 9.14% over six months. The stock has breached the $57 support level established in prior analysis, with the current price of $56.58 representing the lowest level since early 2026. The technical deterioration reflects sector-wide weakness following General Mills' guidance cut and heightened regulatory concerns around processed foods, though the positive YTD performance suggests underlying resilience relative to the broader packaged food sector.

Investment Thesis

Mondelez maintains a compelling long-term value proposition anchored by its wide economic moat, diversified brand portfolio including Oreo, Cadbury, and Ritz, and superior emerging market exposure at 40% of sales versus 25-30% for peers. The company targets 3-5% organic sales growth through expanded distribution, brand investment, and innovation acceleration, with management projecting 10% earnings growth from 2026 to 2029. Strategic initiatives include empowering local leadership, developing trend-aligned products, and pursuing selective acquisitions to broaden geographic and category presence. The 18% discount to fair value at 17x 2026 earnings, combined with a 3.3% dividend yield, offers attractive risk-adjusted returns as cocoa price deflation provides margin relief beginning in 2027.

Thesis Status

The investment thesis remains intact despite near-term headwinds. The processed food scrutiny represents a sentiment challenge rather than a fundamental deterioration, as CEO Van de Put emphasized adherence to science-based regulation. The sector-wide selloff following General Mills' guidance cut created valuation compression across the category, but Mondelez's differentiated emerging market exposure and wide-moat positioning support the long-term growth algorithm. The anticipated cocoa price relief in 2027, following a 30% decline from May peaks, validates the margin expansion component of the thesis. However, the thesis faces elevated execution risk as the company navigates consumer health concerns while maintaining pricing power and market share across its global portfolio.

Key Drivers

Regulatory and consumer scrutiny of processed foods intensified following Trump administration focus on health issues, with CEO Van de Put defending the category's necessity while committing to science-based compliance. This triggered a 4.4% decline on February 18, though the broader sector weakness from General Mills' guidance cut amplified the selloff. Cocoa price volatility continues to impact margins, with prices declining 30% from May peaks but hedging strategies delaying benefits until 2027. The global packaged food market is projected to grow from $6.61 trillion in 2026 to $8.15 trillion by 2031, with Asia-Pacific's 33% market share and emerging market urbanization supporting Mondelez's geographic positioning. Private-label competition intensifies as retailers improve quality perception, pressuring branded manufacturers on price and market share.

Technical Analysis

MDLZ exhibits a clear downtrend across all timeframes under six months, with the current $56.58 price breaking below the $57 support level and extending losses to 9.14% over six months. The stock has declined for seven consecutive sessions since the March 5 report, establishing a pattern of lower highs and lower lows. The $59 level, which served as support in early March, now represents initial resistance. Despite the technical weakness, the 5.11% YTD gain indicates relative outperformance during the January-February period before the recent selloff. Key resistance levels are $59 (prior support turned resistance) and $61 (the critical level identified in previous reports), while support emerges at $56 and the psychological $55 level. The consistent selling pressure suggests momentum remains negative in the near term.

Bull Case

Bear Case

Get a message when the MDLZ picture changes — the agent team watches the levels and the news for you.Create a free account

More MDLZ analyses